Diarrhea Relief

Aloe, Citrullus Colocynthis, Croton Tiglium, Lycopodium Clavatum, Magnesium Sulfate Heptahydrate, Phosphoric Acid, Thuja Occidentalis

Trp Company
Human Otc Drug
NDC 17312-029

Diarrhea Relief also known as Aloe, Citrullus Colocynthis, Croton Tiglium, Lycopodium Clavatum, Magnesium Sulfate Heptahydrate, Phosphoric Acid, Thuja Occidentalis is a human otc drug labeled by 'Trp Company'. National Drug Code (NDC) number for Diarrhea Relief is 17312-029. This drug is available in dosage form of Tablet, Orally Disintegrating. The names of the active, medicinal ingredients in Diarrhea Relief drug includes Aloe - 5 [hp_X]/1 Citrullus Colocynthis Fruit Pulp - 6 [hp_X]/1 Croton Tiglium Seed - 6 [hp_X]/1 Lycopodium Clavatum Spore - 6 [hp_X]/1 Magnesium Sulfate Heptahydrate - 6 [hp_X]/1 Phosphoric Acid - 6 [hp_X]/1 Thuja Occidentalis Leafy Twig - 6 [hp_X]/1 . The currest status of Diarrhea Relief drug is Active.

Drug Information:

Drug NDC:	17312-029
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Diarrhea Relief
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Aloe, Citrullus Colocynthis, Croton Tiglium, Lycopodium Clavatum, Magnesium Sulfate Heptahydrate, Phosphoric Acid, Thuja Occidentalis
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Trp Company
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Tablet, Orally Disintegrating
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	ALOE - 5 [hp_X]/1 CITRULLUS COLOCYNTHIS FRUIT PULP - 6 [hp_X]/1 CROTON TIGLIUM SEED - 6 [hp_X]/1 LYCOPODIUM CLAVATUM SPORE - 6 [hp_X]/1 MAGNESIUM SULFATE HEPTAHYDRATE - 6 [hp_X]/1 PHOSPHORIC ACID - 6 [hp_X]/1 THUJA OCCIDENTALIS LEAFY TWIG - 6 [hp_X]/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	15 Apr, 2015
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	10 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2024
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	TRP Company
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UNII:	V5VD430YW9 23H32AOH17 0HK2GZK66E C88X29Y479 SK47B8698T E4GA8884NN 1NT28V9397
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class:	Calculi Dissolution Agent [EPC] Increased Large Intestinal Motility [PE] Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] Inhibition Small Intestine Fluid/Electrolyte Absorption [PE] Magnesium Ion Exchange Activity [MoA] Osmotic Activity [MoA] Osmotic Laxative [EPC] Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
17312-029-14	1 BOTTLE in 1 PACKAGE (17312-029-14) / 50 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE	15 Apr, 2015	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Diarrhea Relief

Aloe & more..

Tablet, Orally Disintegrating
TRP Company
NDC: 17312-029

Purpose:

Aloe socotrina hpus - jellylike stools, abdominal discomfort colocynthis hpus - cramping, sudden evacuation croton tiglium hpus - gurgling in intestines, loose, watery stools lycopodium clavatum hpus - gas, bloating magnesia sulphurica hpus - cramping, bad taste in mouth phosphoricum acidum hpus - loud rumbling, weakness, fatigue thuja occidentalis hpus - mucous in stools

Product Elements:

Diarrhea relief aloe, citrullus colocynthis, croton tiglium, lycopodium clavatum, magnesium sulfate heptahydrate, phosphoric acid, thuja occidentalis thuja occidentalis leafy twig thuja occidentalis leafy twig phosphoric acid phosphoric acid magnesium sulfate heptahydrate magnesium cation mannitol sorbitol crospovidone cellulose, microcrystalline copovidone silicon dioxide lactose magnesium stearate lycopodium clavatum spore lycopodium clavatum spore croton tiglium seed croton tiglium seed citrullus colocynthis fruit pulp citrullus colocynthis fruit pulp aloe aloe trp

Indications and Usage:

Uses:* according to homeopathic indications these ingredients temporarily relieve symptoms such as: â¢ abdominal discomfort â¢ cramping â¢ loose, watery stools â¢ gas â¢ bloating â¢ loud rumbling â¢ sudden evacuation â¢ mucous in stools. * these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration.

Warnings:

Warnings: use only after diagnosis by a physician and under the supervision of a physician. this product is intended to complement, not replace, standard medical treatment. initial worsening of symptoms may occur. a physician should always be consulted to rule out serious causes.

In case of overdose, get medical help or contact a poison control center right away. stop use and ask a doctor if: you experience worsening symptoms. if symptoms last longer than 7 days. you get abdominal swelling or bulging.

Do Not Use:

Dosage and Administration:

Directions suitable for adults and children 12 years and above. dissolve entire tablet under tongue. do not chew or swallow whole. take 1 tablet 3 times a day or as directed by a physician. use up to 6 times a day as needed. take at least 10 minutes before or at least 10 minutes after eating or drinking. children under the age of 12: consult a physician before use. homeopathic remedies may not be effective for everyone.

Package Label Principal Display Panel:

Box label

Further Questions:

Www.thereliefproducts.com, 1-888-969-6855

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.